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Abstract
In neonates, cardiovascular system development does not stop after the transition from intra-uterine to extra-uterine
life and is not limited to the macrocirculation. The microcirculation (MC), which is essential for oxygen, nutrient, and
drug delivery to tissues and cells, also develops. Developmental changes in the microcirculatory structure continue
to occur during the initial weeks of life in healthy neonates. The physiologic hallmarks of neonates and developing
children make them particularly vulnerable during critical illness; however, the cardiovascular monitoring possibilities
are limited compared with critically ill adult patients. Therefore, the development of non-invasive methods for
monitoring the MC is necessary in pediatric critical care for early identification of impending deterioration and
to enable the initiation and titration of therapy to ensure cell survival. To date, the MC may be non-invasively
monitored at the bedside using hand-held videomicroscopy, which provides useful information regarding the
microcirculation. There is an increasing number of studies on the MC in neonates and pediatric patients; however,
additional steps are necessary to transition MC monitoring from bench to bedside. The recently introduced concept
of hemodynamic coherence describes the relationship between changes in the MC and macrocirculation. The loss of
hemodynamic coherence may result in a depressed MC despite an improvement in the macrocirculation, which
represents a condition associated with adverse outcomes. In the pediatric intensive care unit, the concept of
hemodynamic coherence may function as a framework to develop microcirculatory measurements towards
implementation in daily clinical practice.
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Background
The cardiorespiratory system delivers oxygen and nutri-
ents to meet oxygen and nutrient demands to support
cellular and organ function. Hemodynamic monitoring
is vital to identify changes in clinical conditions and
evaluate interventions. It is important that hemodynamic
monitoring is easily applied, reproducible, quantitative,
and warns the physician before hemodynamic deterior-
ation leads to cellular and organ injury. In addition to
hemodynamic monitoring, a thorough understanding of
physiology and pathophysiology is important in the care
of critically ill patients. However, the pediatric intensivist
and anesthesiologist face specific age- and development-
related problems, such as different body proportions,
increased metabolic rate, and reduced respiratory and
cardiovascular reserves, which makes the care of these
patients particularly challenging.
This review focuses on the role of monitoring the
microcirculation (MC) in (not yet) hemodynamically
unstable pediatric patients and the specific problems
that pediatric intensivists and anesthesiologists face on
a daily basis in the care of this heterogeneous patient
group. Cardiovascular development, the role of oxygen
during development in the pediatric population, and the
role of the MC are described. The specific problems en-
countered during hemodynamic instability, the limitations
of cardiovascular monitoring, and how monitoring the MC
may aid in decision making when initiating or evaluating
therapies are subsequently discussed. In this context, we
focus on the recently introduced concept of hemodynamic
coherence (HC), which may provide a framework for
future decision-making. HC describes the relationship
between the MC and the macrocirculation. When HC
is present, improvements in the macrocirculation will
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lead to improvements in the MC. However, an opti-
mally functioning macrocirculation does not guarantee
an adequate microcirculatory perfusion. In specific situa-
tions, such as sepsis, HC is lost and despite an improved
macrocirculation, the MC may remain dysfunctional. Fur-
thermore, when attempts to improve the macrocircula-
tion do not improve the MC, additional interventions
may worsen the MC [1]. The review concludes with a
discussion regarding microcirculatory targeted therapy
in the future.
Cardiovascular development
Cardiovascular development in children is a highly com-
plex process. Major changes with important physiological
consequences occur in the initial hours to days following
birth. Further growth and development during the neo-
natal period and infancy change the physiology much less
dramatically and the cardiovascular physiology begins to
more closely resemble the adult physiology. The physi-
ology in younger children continues to change but the
physiology of older children becomes similar to adult
physiology. Cardiovascular development affects import-
ant physiological parameters, such as the pulmonary and
systemic vascular resistance (SVR), ventricular stroke
volume, organ blood flow, and heart rate and thus com-
pensatory mechanisms [2].
The transition from fetal to extra-uterine life is a com-
plex process that affects nearly every organ; however,
major changes predominately occur in the cardiovascular
system. Fetal life is characterized by the presence of the
low resistance placental circulation and fetal communica-
tion, the ductus arteriosus, the ductus venosus, and the
foramen ovale, as well as development in a relatively hyp-
oxic environment with high hematocrit. The left and right
ventricular pressures are equal with right heart predomin-
ance [2]. In addition, the pulmonary vascular resistance is
high and changes during fetal life, whereas a substantial
decrease in the vascular resistance occurs after birth [3, 4].
Of note, the pulmonary vascular reactivity to oxygen
increases during pregnancy, with potential implications
for pulmonary hypertension and right to left shunting
after birth [3, 4]. After clamping the umbilical cord, the
fetal circulation rapidly transforms into an adult circula-
tion. Under the influence of various hormones released
during labor and delivery, as well as the removal of the
low resistance placental circulation, the SVR suddenly
increases, whereas the pulmonary vascular resistance de-
creases [2]. These changes result in increased pulmonary
blood flow and increased left ventricle preload. The result
is an increased left ventricular output that peaks 2 h after
birth [5, 6]. Following the closure of the foramen ovale,
the ductus arteriosus closes, which partially explains the
decrease in the left ventricular output in the 22 h after the
peak left ventricular output [2]. The closure of the ductus
arteriosus is typically complete after 48–72 h, although it
may be delayed when shunting across the ductus persists
[6]. The separation of the pulmonary and systemic circula-
tion leads to an arterial oxygen saturation increase from
60–70 % one minute after birth to near normal adult
values after 8–10 minutes [5, 7, 8]. The ventricles of new-
borns are less compliant with decreased diastolic function;
moreover, the response to inotropes and volume loading
are less pronounced and an increased afterload is less well
tolerated [9]. Both the SVR and left ventricular afterload
increase; thus, there is limited inotropic reserve.
Following the initial drastic changes in the cardiovas-
cular physiology after birth, the cardiovascular system
continues to change more slowly and the differences
between child physiology and adult physiology become
less clear [10]. In the first few years following birth, the
heart adapts to the new preload and afterload and the
inotropic reserve capacity increases [9]. After its initial
increase, the SVR decreases, particularly in the first 5 years
of life. In this same period, the stroke volume index in-
creases and stabilizes to adult values at approximately
5 years of age. The stroke volume continues to increase
until 13 years of age. The cardiac index increases in the
first 3 years but decreases after 5 years of age to adult
levels after 10 years of age [10].
The normal transition and cardiovascular development
are well-balanced processes; however, the physiological
remnants of fetal life and the consequences of a develop-
ing cardiovascular system may become obvious when the
normal physiology is under pressure and compensatory
mechanisms are needed. In critically ill children in the first
years of life, the oxygen and metabolic demands are in-
creased, exhibit less variation, and lack a hypermeta-
bolic response [11]. During sepsis in adults, despite an
increased end diastolic volume, septic cardiac dysfunction
causes an increased end systolic volume and the stroke
volume index remains within the normal range [12]. In
addition, the heart rate and cardiac index both increase
during sepsis in adults [12, 13]. In children with septic
shock, despite impaired contractility, the left ventricular
preload presumably does not increase and compensation
mainly depends on an increasing heart rate. This is limited
by the normally high heart rate in neonates and infants
and, to a lesser extent, in children past infancy [14]. How-
ever, more recent studies demonstrate that increases in
the cardiac output (CO) can be achieved by an increased
stroke volume [15–18]. Cardiac function in neonates and
infants is characterized by an increased contractile state,
increased sensitivity to afterload, and increased oxygen de-
mands at an increased heart rate or preload state, which is
less clear for children [15, 16]. In contrast to adults, in
which a high cardiac index and low SVR are the hallmarks
of sepsis, the presentation of pediatric patients differs. In
central venous catheter-related sepsis 94 % of the pediatric
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patients presented with high cardiac index and low SVR
but in community acquired sepsis 86 % presented with a
low to normal cardiac index and variable SVR [19].
Assessment of cardiovascular compromised pediatric
patients
The currently available techniques to assess cardiovascu-
lar compromised pediatric patients and evaluate therapy
include both invasive techniques, such as the direct meas-
urement of CO, and non-invasive techniques, such as
echocardiography and physical examination. Furthermore,
central and mixed venous saturation have been used as
surrogate markers for the adequacy of CO. The capil-
lary refill time, peripheral temperature, and serum lac-
tate levels are used as markers of tissue perfusion, and
measurements of the lung water and “fluid responsive-
ness” may be used to guide fluid therapy [20]. Persistently
low CO measurements in septic children are associated
with increased mortality [21, 22].
The clinical estimation of CO is unreliable, which has
been demonstrated in infants and children following car-
diac surgery [23]. The gold standard for invasive measure-
ment of CO is the pulmonary artery catheter, which is not
widely used in children [24, 25], not only because of its
size but also because pulmonary artery catheter usage in
adults has not been demonstrated to be effective and is
associated with an increased length of stay, mortality, and
costs [26–28]. Less invasive alternatives have been devel-
oped, such as Doppler signals, dilution-based methods,
and bioimpedance. Following its use for approximately
20 years in pediatrics, Lemson et al. validated transpul-
monary thermodilution in lambs as a precise method to
measure CO [24, 25, 29]; however, it requires both central
venous and arterial access and is typically unsuitable for in-
fants under 3.5 kg. Moreover, the validity and relevance of
CO measurement using transpulmonary dilution tech-
niques in patients with intra-cardiac or extra-cardiac
shunts is questionable. Echocardiographic estimations
of CO are highly operator-dependent, require extensive
training, and are, therefore, often inaccurate; moreover,
research in children focuses on different techniques
and its validation under different conditions [20, 30].
Venous oximetry comprises an invasive measurement;
however, it is used as an alternative for invasively mea-
sured CO. Central venous saturation represents a poor
surrogate for determining the adequacy of CO [31]. Cen-
tral venous saturation is typically measured in the superior
vena cava because measurements from the inferior vena
cava may provide deviating results [32, 33]. A further
complicating feature in the interpretation of venous satur-
ation is the matter of high mixed venous saturations in
critically ill patients as a result of impaired oxygen extrac-
tion and cardiac and microcirculatory shunts [9, 20, 34].
Thus, it is unclear whether central venous saturation
measurements have additional value in pediatric critical
care; nevertheless, central venous saturation is part of the
Surviving Sepsis Campaign protocol for children [20, 35].
In summary, CO measurements in children are difficult
and are much less frequently performed compared with
adults.
For the assessment of tissue perfusion, the capillary refill
time, temperature, and serum lactate concentrations are
used. A prolonged capillary refill time may indicate an
early warning sign of cardiovascular failure. Despite a pre-
dictive value in an emergency department [36, 37], in an
intensive care unit, the capillary refill time exhibits no cor-
relation with hemodynamic variables, such as the cardiac
index, central venous pressure, stroke volume index, and
SVR, in pediatric patients following cardiac surgery [38].
In the general pediatric intensive care unit population,
only a severely prolonged capillary refill time correlates
with the stroke volume index and lactate concentration;
however, this correlation is relatively weak [38]. In this
same study, Tibby et al. demonstrated that the core-
peripheral temperature gap closely correlated with the ca-
pillary refill time; however, there was no correlation with
the previously described hemodynamic parameters [38].
Lactate is used as a marker of tissue perfusion but in-
creased lactate levels may also arise from increased
production via activated white blood cells, inflamma-
tory mediator-accelerated glycolysis and catecholamine-
stimulated muscle, or decreased clearance during mito-
chondrial dysfunction or liver failure [39, 40]. In various
circumstances, a high serum lactate concentration has
prognostic value in a pediatric intensive care unit [41–45].
To date, however, there is no evidence in pediatric patients
indicating improved outcome when a reduction in lactate
levels is used as a target in goal-directed therapy [39, 46].
Taken together, no bedside tool to date reliably informs
the pediatric intensivist or pediatric anesthesiologist re-
garding oxygen delivery in critically ill pediatric patients
or is able to warn the clinician of impending cardiovascu-
lar deterioration. Most therapeutic interventions aim to
improve oxygen delivery to the tissues and cells. However,
the effect of blood transfusions to optimize the oxygen-
carrying capacity of the circulation, fluid administration,
inotropes, and vasopressors is measured using the previ-
ously described (macrocirculatory) parameters as end
points. However, these interventions only improve oxygen
delivery to the tissues and cells when HC is preserved, i.e.,
the effects on the macrocirculatory parameters are also
effective in restoring the MC [1]. Also, the effects of these
interventions on the MC are not yet clinically monitored
at the bedside.
Monitoring of the pediatric MC
The final steps in oxygen delivery by the cardiovascular
system are to deliver oxygen to the MC and diffusion of
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oxygen to cells. Hand-held videomicroscopy, utilizing or-
thogonal polarization, spectral, sidestream dark field, and
incident dark field imaging techniques, may readily be
used to visualize the MC at the bedside. Currently, con-
sensus meetings are being held to determine the optimal
method to analyze and obtain functional microcirculatory
parameters from the images obtained by hand-held video-
microscopy. Several studies in pediatric patients have ad-
dressed the microcirculation in various disease states and
different age groups [47–49].
The MC consists of vessels with a diameter smaller
than 100 μm: arterioles, capillaries, and venules [50]. An
optimally functioning macrocirculation does not guaran-
tee adequate microcirculatory perfusion if therapeutic
interventions do not result in a coherent improvement of
the MC. Parameters such as the arteriolar tone, hemorheol-
ogy, endothelial function, and capillary patency also deter-
mine flow in the MC [50]. In adult patients with severe
sepsis and traumatic hemorrhagic shock, the loss of coher-
ence between the resuscitated macrocirculation and MC
has been demonstrated to be the most sensitive and specific
hemodynamic indicator associated with increased multi-
organ failure and mortality [51–56]. In critically ill children
with sepsis, a persistently altered MC has been associated
with increased mortality [48]. Indices of microcirculatory
blood flow may also serve as early indicators of decreased
perfusion of the MC and potentially warn clinicians regard-
ing the development of multi-organ failure [57–59]. Thus,
MC measurement must be considered a valuable extension
of current hemodynamic monitoring techniques [9, 60].
Readily accessible sites for MC measurements using
hand-held videomicroscopy include the buccal and sublin-
gual MC. In (preterm) neonates, the reduced thickness of
the skin enables transcutaneous measurements of the MC
[61–63]. Orthogonal polarization spectral imaging was the
first hand-held videomicroscopy technique that visualized
the MC and was succeeded by sidestream dark field im-
aging in 2007 [64–66]. Recently, the CytoCam, which is
based on incident dark field imaging, was introduced [67].
The CytoCam uses a different illumination technique and
is smaller and lighter and has a higher optical resolution
[68]. In preterm neonates, transcutaneous measurements
using an incident dark field have been demonstrated to be
superior to a sidestream dark field in terms of the detected
number of vessels, and the perfusion of the vessels could
also be more accurately detected [68]. Moreover, the im-
aging quality scores for illumination, focus, and pressure
were better for the incident dark field compared with side-
stream dark field imaging [68].
To differentiate capillaries from venules, in general, a
cutoff value of 20 μm is used [69]. In preterm and term
neonates, however, small vessels are, on average, 8.4 μm;
moreover, in term neonates, the capillary diameter does
not exceed 10 μm [47]. Thus, in pediatric studies, a
general cutoff value of 10 μm is used [48, 49, 70–74].
Ideally, multiple measurements should be performed per
organ in at least three different sites [69]. To describe
the MC, descriptive parameters such as perfused vessel
density, as a measure of functional capillary density, have
been introduced. The functional capillary density repre-
sents the functional volume of flowing red blood cell
(RBC)-filled capillaries per unit area of tissue. Additional
parameters include the proportion of perfused vessels
and total vessel density [69]. The measurement of the
flow is the major technical challenge, which is why a
semi-quantitative index referred to as the microvascular
flow index has been developed [75, 76]. It must be noted
that this index was specifically designed for sepsis and
may not be well suited for other states of hypoperfusion,
such as heart failure with a progressive decrease in flow.
Depending on the disease state, the MC may be very
heterogeneous, particularly during distributive shock as
exhibited in sepsis [59]. To this end, a heterogeneity
index was introduced to describe this property of the
MC [59, 69]. A recent paper provides a comprehensive
review regarding the current state-of-the-art of hand-
held videomicroscopy and the difficulties encountered in
the application of this technique [77]. Nevertheless,
visualization of the MC has been demonstrated to be
feasible and has introduced a novel field of research and
a new modality for non-invasive hemodynamic monitor-
ing in the pediatric population (Tables 1 and 2).
The MC in critically ill pediatric patients
Several studies in pediatric patients have assessed the
MC in different clinical settings and disease states. Most
studies have been performed in preterm and term
neonates in which the physiological differences with the
adult population vary most. A smaller selection of
studies have been performed in the pediatric intensive
care unit, with a very heterogeneous group in terms of
age, physiology, and underlying diagnoses.
Studies in neonates
The MC changes in the first weeks of life in healthy term
and preterm infants. In various disease states and different
age groups, changes in the MC following interventions
have been described (Table 1). Changes in the MC have
been associated with poor outcomes in various disease
states. Monitoring the MC was first reported in 2002 in
preterm and term neonates during the first 5 days of life
[47]. The authors demonstrated that the RBC velocity
increased in preterm infants during the first 5 days of
life and was correlated with a decrease in hemoglobin
levels [47]. In the first weeks of life of term and preterm
infants, the MC changes likely because of an adaptation to
extra-uterine life. In neonates, the functional capillary
density decreases in the first week of life [62, 71]. In
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preterm infants, the functional capillary density of the
skin decreases during the first month, which is corre-
lated with the physiological decrease in hemoglobin
levels and environmental incubator temperature [62].
The functional capillary density of both the buccal
mucosa in term and the skin in preterm infants
decreases in the first week, which suggests that these
changes represent adaptation to extra-uterine life ra-
ther than disturbed development as a result of prema-
ture birth [62, 71]. Early research suggests that the
MC of the skin resembles that of adults at the age of
3 months [78]. Whether this is true for all micro-
vascular beds remains elusive. Ambient temperature,
an increase in oxygen consumption because of the
increased work of breathing and gastrointestinal func-
tion, and high levels of fetal hemoglobin in the first
months of life may be compensated for by increased
macrocirculatory and microcirculatory blood flow [9].
The high functional capillary density in the first week
of life may be attributed to increased CO and high
hematocrit levels, although autoregulation of the MC
may also play a role [9, 79, 80].
In various disease states, changes in the MC have been
described following interventions (Table 1). In anemic
preterm infants, the administration of a blood transfusion
resulted in a parallel increment in the functional capillary
density, which lasted at least 24 h [61]. Decreasing
hematocrit with a partial exchange transfusion in neonates
Table 1 Neonatal studies of the microcirculation using orthogonal polarization spectral, sidestream dark field or incident dark
field imaging
Study N Age group Technique/site Disease Intervention Outcome
Genzel-Boroviczény
et al. 2002 [47]
37 Preterm/term OPS/skin - - Feasibility study; RBC velocity increases in preterm infants,
correlated with a decrease in Hb
Genzel-Boroviczény
et al. 2004 [61]
13 Preterm OPS/skin Anemia RBC
transfusion
FCD improves at least 24 h
Kroth et al. 2008 [62] 25 Preterm OPS/skin - - FCD decreases in first 4 weeks of life, correlated with Hb
levels and incubator temperature
Top et al. 2009 [70] 14 0–18 days OPS/buccal Respiratory
failure




25 Preterm OPS/skin Infection - FCD decreases 1 day before clinical signs of infection




15 Term SDF/skin Polycythemia PET PET improves FCD
D’Souza et al.
2011 [111]
115 Preterm/term OPS/skin LBW - FCD is increased in LBW compared with normal birth
weight infants
Top et al. 2012 [73] 21 Term OPS/buccal Respiratory
failure
VA-ECMO FCD is maintained but not immediately improved
following initiation of VA-ECMO
Ergenekon et al.
2013 [112]
14 Term SDF/skin Asphyxia TH Flow is impaired compared with controls, flow improves
after re-warming
Alba-Alejandre
et al. 2013 [113]
47 Term OPS/skin Infection Flow is decreased during infection, no difference in FCD
Schwepcke et al.
2013 [114]
21 Preterm SDF/skin Hypotension FCD is increased in hypotensive neonates 6 h after birth;
it subsequently normalized to normotensive control levels
Raghuraman et al.
2013 [115]
141 Preterm/term OPS/skin - - FCD is increased in twins compared with singletons, low
birth weight was associated with lower FCD
Buijs et al. 2014 [74] 56 Term SDF/buccal CDH - Loss of hemodynamic coherence; severely impaired MC
after dopamine predicts need for the addition of
(nor)epinephrine
Van den Berg et al.
2014 [116]
28 Term SDF - - Buccal measurements of vessel density are reproducible,
cutaneous are not reproducible
Van Elteren et al.
2015 [68]
20 Preterm SDF/IDF - - IDF is superior compared with SDF in vessel visualization,
visualization of perfusion, and image quality score
CDH congenital diaphragmatic hernia, FCD functional capillary density, Hb hemoglobin, IDF incident dark field imaging, LBW low birth weight, OPS orthogonal
polarization spectral imaging, PDA persistent ductus arteriosus, PET partial exchange transfusion, RBC red blood cell, SDF sidestream dark field imaging, TH therapeutic
hypothermia, VA-ECMO veno-arterial extracorporeal membrane oxygenation
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with polycythemia increased the microvascular flow
index for small and larger vessels, which suggests an
optimal hematocrit for the maximal functional capillary
density and microvascular flow index. In neonates with
severe respiratory failure, the functional capillary dens-
ity was decreased compared with non-ventilated con-
trols; however, it significantly increased as the clinical
conditions improved and the patients were removed
from extracorporeal membrane oxygenation (ECMO)
support [70]. The observed improvement in the func-
tional capillary density was most likely a result of a
combination of the overall clinical improvement, ad-
ministration of vasodilators, and decreased levels of va-
sopressors [70]. During ECMO for severe respiratory
failure, the functional capillary density, microvascular
flow index, and heterogeneity index did not improve
following the initiation of ECMO, although ECMO ap-
peared to prevent the further deterioration of the MC
[73]. Preterm infants with a patent ductus arteriosus
(PDA) with a left to right shunt that resulted in
decreased peripheral perfusion had a lower functional
capillary density compared with preterm infants with-
out a PDA [81]. Interestingly, there appeared to be a
shift in the microcirculatory flow to relatively smaller
vessels in the PDA group [81]. Correction of the PDA
resulted in an improvement of the functional capillary
density to control values and the shift to relatively
more small vessels disappeared [81]. Dopamine im-
proved the macrocirculation in neonates with CDH;
however, it did not hemodynamically coherent improve
the MC, and the MC also did not improve after the
addition of epinephrine or norepinephrine, whereas
these treatments did increase the heart rate and blood
pressure [74]. Adrenergic vasopressor treatment may
be deleterious for the MC [82], and similar results
have been demonstrated in adults [83, 84]. It remains
unclear how the MC in critically ill neonatal patients
may be optimally improved. To date, only blood
transfusion during anemia has been reported to im-
prove the MC in terms of increasing the functional
capillary density.
Studies in pediatric patients
Most studies have been performed in neonates, but sev-
eral studies have focused on older children as well
(Table 2). In patients ranging from 0–3 years old, Top
et al. [71] reported that functional capillary density
changes in the first week, after which there was no cor-
relation between age and the functional capillary dens-
ity. Also in patients ranging from 0–3 years old, cardiac
surgery with or without cardiopulmonary bypass re-
sulted in a transient reduction of the microvascular
flow index and functional capillary density [85]. Only
two studies in children demonstrated changes in the
MC after an intervention. In eight patients with hypox-
emic respiratory failure, five of whom suffered from
congenital diaphragmatic hernia, the buccal functional
capillary density significantly improved following the
initiation of inhaled nitric oxide (NO) [72]. Inhaled NO
did not affect the systemic blood pressure, which makes
the mechanism by which NO improves the MC unclear
[72]. In anemic hematology or oncology patients, a
blood transfusion increased the total vessel density but
not to normal values [86]. In pediatric patients, similar
to neonates, it remains unclear how to best improve
the MC in terms of the functional capillary density.
Table 2 Pediatric studies of the microcirculation using orthogonal polarization spectral or sidestream dark field
Study N Age group Technique/site Disease Intervention Outcome
Top et al. 2010 [71] 45 0–3 years OPS/buccal - - FCD decreases after the first week of life
Top et al. 2011 [48] 18 0–15 years OPS/buccal Septic shock - FCD does not differ on day 1, non-survivors have
persistently low FCD
Top et al. 2011 [72] 8 0–3 years OPS/buccal Respiratory failure iNO iNO increases FCD without altering macrocirculatory
parameters
Paize et al. 2012 [117] 60 0–6 years SDF/sublingual MCD - FCD is decreased at admission; however, it
increases when MCD resolves. HI is correlated with
duration of ventilation
Buijs et al. 2014 [49] 20 0–16 years SDF/buccal Cardiac arrest TH FCD and flow are impaired during TH; however,
they recover after re-warming. Severe impairment
was associated with mortality
Nussbaum et al. 2015 [85] 40 0–3 years SDF/ear Cardiac surgery/
catheterization
- Transient reduction in MFI and PVD after cardiac
surgery with and without cardiopulmonary bypass
Schinagl et al. 2016 [86] 37 Unknown SDF/buccal Anemia Blood Tx Transfusion increased TVD with decreased RBC
velocity, particularly during infection
FCD functional capillary density, HI heterogeneity index, iNO inhaled nitric oxide, MCD meningococcal disease, MFI microvascular flow index, OPS orthogonal
polarization spectral imaging, PVD perfused vessel density, RBC red blood cell, SDF sidestream dark field imaging, TH therapeutic hypothermia, TVD total vessel
density, Tx transfusion
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Monitoring the MC to guide patient management
The studies in pediatric critically ill patients have mainly
been observational in nature, which provides vital informa-
tion but does not guide the initiation or titration of therapy
to improve the MC. One study indicated alterations in
the MC that preceded clinical deterioration, and a lim-
ited number of studies have demonstrated prognostic
value (Table 1). Nevertheless, monitoring the MC may
provide valuable information regarding the loss of HC.
Four types of alterations in the MC have been identified
that underlie the loss of HC. Weidlich et al. [87] performed
the first study that demonstrated MC measurements may
be used to initiate therapy. This study indicated that
the functional capillary density decreased one day be-
fore changes in the laboratory parameters and preceded
the prescription of antibiotics in preterm infants. In
septic pediatric patients, a persistently altered MC was
prognostic for mortality and was demonstrated to be
superior to the severity of the illness score using the
pediatric risk of mortality 2 score in the prediction of
mortality [48]. Buijs et al. [49] reported poor outcomes
in pediatric patients with early buccal microcirculatory
impairment during therapeutic hypothermia following
cardiac arrest. Re-warming improved the impaired MC
to control values; however, the functional capillary
density of the vessels with a diameter of 11–100 μm
and the microvascular flow index before the initiation
of therapeutic hypothermia were significantly decreased
in non-survivors [49]. Coherence between the systemic
circulation and the MC is lost when improvements in
systemic parameters are not reflected by improvements
in the MC [1]. This issue may occur particularly in states
of shock, inflammation, reperfusion, and infection, as well
as resuscitation damage to normal cellular sensing mecha-
nisms [1, 51–54, 88]. In adults, the loss of coherence
predominately occurs in sepsis [52, 53, 56]. Loss of HC
also occurs in pediatric patients. In neonates with
congenital diaphragmatic hernia, increasing the mean
arterial blood pressure with catecholamines did not
improve the MC [74].
Four types of alterations in the MC have been delin-
eated that may underlie the loss of HC (Fig. 1) [1]. The
concept of hemodynamic coherence, including the four
types that explain the loss of coherence, may become
vital when measurements of the MC are ready to be
translated into the clinical setting in the future. The four
types of loss of coherence have been demonstrated dur-
ing the previous decade, mainly in adult studies; how-
ever, they require further prospective evaluations in
pediatric patients, particularly in terms of the effective-
ness in improving patient outcome. In type 1, which is
typically observed in sepsis, there is heterogeneity in the
perfusion of the MC, with obstructed capillaries next to
capillaries with normal flow (Fig. 1). The persistence of
this type of loss of coherence is associated with a poor
outcome in adult sepsis [51, 56]. In pediatric patients
who require ECMO, type 1 alterations have been de-
scribed, which were associated with poor outcome [48].
The heterogeneity index has been introduced to describe
type 1 alterations [53]. Type 1 abnormalities warrant the
administration of antibiotics and vasoactive agents
(vasodilators) to promote the patency of the MC [1, 35],
but prospective studies are needed. Type 2 is character-
ized by hemodilution, which is mainly caused by exces-
sive fluid administration and results in the loss of RBC
perfused vessels (Fig. 1). This type has predominately
Fig. 1 Microcirculatory alterations that underlie the loss of
hemodynamic coherence between the macro- and microcirculations
resulting in tissue hypoxia. Type 1 comprises a condition with a
heterogeneous perfusion of the microcirculation as exhibited by
septic patients with obstructed capillaries next to perfused capillaries,
which results in a heterogeneous oxygenation of the tissue cells. Type
2 occurs as a consequence of hemodilution, with the dilution of
microcirculatory blood resulting in the loss of RBC-filled capillaries and
increasing the diffusion distance between oxygen carrying RBCs and
tissue cells. Type 3 alterations result in a stasis of microcirculatory RBC
flow induced by an increased arterial vascular resistance, vasopressor
therapy, increased venous pressure, or hyperoxia. Type 4 alterations
involve edema caused by capillary leak syndrome and results in an
increased diffusive distance and reduced ability of oxygen to reach
tissue cells. Adapted from [1]
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been described in patients who underwent cardiac sur-
gery [89]. This issue may be corrected by blood transfu-
sions to improve the hematocrit levels, which thereby
increase the oxygen transport capacity of the microcir-
culation [90, 91]. Several studies have shown the ability
of blood transfusions to improve the MC. Yuruk et al.
[90] showed an increase in functional capillary density
after blood transfusion, increasing hemoglobin levels
from 7.1 to 8.5 g/dL, during cardiac surgery. Comparing
transfusions with leukodepleted and non-leukodepleted
RBCs in septic patients, Donati et al. [91] showed that
increasing hemoglobin levels from 8.3 to 10.4 g/dL with
leukodepleted blood improved functional capillary dens-
ity. This study also suggests that the quality of the trans-
fused blood influences the increase in FCD. Recently,
Schinagl et al. [86] showed in pediatric patients with
hematological or oncological disease that RBC transfu-
sion, increasing hemoglobin from 7.2 to 8.0 g/dL, im-
proved functional capillary density. Although increasing
blood hemoglobin levels may improve the microcircula-
tion in various clinical settings, we do not suggest to
change transfusion guidelines. The potential role of
inhaled NO in RBC-induced capillary recruitment is
unclear. Top et al. [72] showed an improvement of the
microcirculation after inhaled NO in pediatric patients
with hypoxic respiratory failure. In contrast, Trzeciak et
al. [92] did not show improvement of the MC in patients
with sepsis following inhaled NO. The effect of RBC
transfusion on the MC is likely caused by increasing
blood viscosity. In an animal model of anemia it has
been shown that increasing the blood viscosity increases
functional capillary density (FCD) [93]. The third type
comprises the constriction/tamponade type, in which
the flow in the MC is constricted (Fig. 1). Norepineph-
rine, which is advised for use in the treatment of sepsis
[35], increases the blood pressure by vasoconstriction,
although it simultaneously impairs the RBC flow in the
MC [83, 84]. Inappropriate use of other vasopressors has
also resulted in this effect [94]. Importantly, hyperoxia is
also associated with type 3 alterations of the MC. In
healthy volunteers, increasing the fraction of inspired
oxygen decreases the sublingual functional capillary
density [95]. In animal experiments, administration of
hyperbaric oxygen decreased FCD and may be associated
with what gives the appearance of maldistribution of
perfusion in the MC [96]. Central venous pressures that
exceed 12 mmHg may reduce the perfusion of the MC
by inducing tamponade, which likely occurs via an in-
crease in the post-capillary pressure [97]. The final type
occurs when a capillary leak, endothelial damage, and
loss of glycocalyx barriers lead to edema formation with
an increased diffusion distance (Fig. 1) [1]. This type
may have been involved in patients with severe malaria
treated with a liberal fluid strategy [98]. In a trial of
pediatric patients with malaria or sepsis, this type of loss
of coherence may partially explain the adverse outcome
in the liberal fluid administration group [99, 100].
An altered MC may be the cause of injury or a marker
of cellular injury, since various insults may cause MC
dysfunction. Macrocirculatory dysfunction negatively
affects the MC and local inflammation and hormonal
actions also affect it [1, 101]. In sepsis, endothelial cell
injury and RBC injury may cause dysfunction of the
MC. In the absence of injury, however, (iatrogenic)
dysfunction of the MC can also occur, for example,
following hemodilution or nor-epinephrine infusion
[1, 83, 84, 101]. Of special interest is the interaction be-
tween the MC and mitochondrial function, particularly
during states of shock, sepsis, and resuscitation [102].
When mitochondrial dysfunction occurs, cells may fail to
utilize oxygen regardless of the state of the MC [103].
Irrespective of the cause of dysfunction of the MC, during
an effective resuscitation of the macrocirculation, the MC
should be simultaneously monitored to assure HC. When
HC is lost, monitoring the MC and establishing the type
of loss of HC can guide therapy. The concept of HC and
the four types of alterations that may explain the loss of
coherence are based on experience with monitoring the
MC in the previous decade; however, this concept
requires further prospective evaluations in children
and adults. Larger studies, including observational
studies and randomized trials, are needed to assess
the effectiveness and patient outcome of interventions
based on this concept.
Microcirculatory-targeted therapy in the future
Before measurement of the MC can become a part of the
routine care of critically ill children, three central issues
need to be addressed. First, larger observational studies
are needed to further delineate the role of the MC in vari-
ous disease states in critically ill children and observe the
effect of interventions and outcome. International obser-
vational cohort studies have been performed in critically
ill adults [104]. In randomized trials the effect of monitor-
ing the MC and intervening in the MC on outcome
should subsequently be examined. The second issue is the
validation in observational studies and randomized trials
of the concept of HC as a framework for bedside monitor-
ing and decision-making in children and adults. Third, fu-
ture research should focus on the translation from bench
to bedside of monitoring the MC. Important research
areas are, first, the determination of which functional
parameters best describe the physiological (dys)function
of the MC. Second, the image quality and analyses
should be of high quality and automated to be
instantaneously available at the bedside. Third, the
establishment of the concept of HC as a framework for
MC-targeted therapy at the bedside will require a
Kuiper et al. Critical Care  (2016) 20:352 Page 8 of 12
hardware and software platform that integrates the
monitoring of the macrocirculation with the MC.
Physiological and quantitative parameters based on the
oxygen transport capacity of the MC will need to be in-
troduced based on the classic MC literature related to
oxygen transport to tissues. It is essential for the
optimization of the oxygen carrying capacity of the MC
to ensure proper convective flow, short diffusion dis-
tances, and a sufficient level of hematocrit [105, 106].
For a complete functional description of MC images,
four physiological parameters are needed. First, the avail-
able RBCs in the capillaries are defined by the tube
hematocrit, which is measured from the volume of RBCs
in the capillaries divided by the volume of the capillary
[105, 106]. Second, the oxygen delivery capacity is de-
fined by the discharge hematocrit, which is the tube
hematocrit that flows through the capillary per unit of
time [105, 106]. Third, the oxygen-releasing capacity of
the MC to the tissues is necessary. This is described by
the diffusive capacity of the MC (functional capillary
density). Capillary blood flow is not equal in all capillar-
ies and all capillaries are not necessarily filled by
oxygen-carrying RBCs. This has been described by the
heterogeneity index [53]. This microcirculatory variable
may be more accurately defined by a quantitative assess-
ment of the flow pattern distributions in the MC. With
the current generation of hardware using computer-
controlled imaging sensors, the measurements of these
four parameters at the bedside are within reach.
These functional parameters will be of use to describe
the type of loss of HC present at the bedside (Table 3)
and initiate and titrate therapy. From current knowledge,
a low discharge hematocrit associated with a low con-
vective flow is indicative of hypovolemia and has been
demonstrated to be effectively treated by fluid therapy.
However, if the microcirculatory flow is normal or high,
irrespective of the presence of clinical surrogates of hypo-
volemia, such as lactate and oliguria, fluid therapy has been
demonstrated to be ineffective in improving the micro-
circulatory perfusion [107, 108]. Using the optimization
of the microcirculatory flow to achieve maximum oxy-
gen transport to tissues as an end point, it has been
proposed to administer fluids only following the indica-
tion of a low discharge hematocrit as the ultimate def-
inition of hypovolemia. However, when the functional
capillary density decreases, fluid administration should
be terminated to avoid a type 2 loss of HC [1].
Similarly, microcirculatory-guided therapy has been
proposed for the treatment of hypotension by vasopres-
sor therapy. It has been demonstrated that only a low
functional capillary density associated with hypotension
responded to vasopressor therapy in the presence of a
normal or high functional capillary density, despite the
finding that the presence of hypotension vasopressor
therapy did not improve the microcirculatory flow
[83, 84]. These are examples of microcirculatory-guided
fluid therapy that may be applicable to pediatric patients,
although they must be validated in critically ill pediatric
patients first.
Information from the MC must be integrated with
systemic hemodynamic monitoring to provide an inte-
grative hemodynamic monitoring platform of the cardio-
vascular system to facilitate clinical decisions and the
titration of therapies. More sensitive information may
also be obtained by further development of hand-held
videomicroscopy, such as a prolonged observation of a
single microcirculatory unit, inclusion of extra wave-
lengths of light to measure the RBC oxygen saturation,
and an increased magnification to visualize subcellular
structures, such as the glycocalyx and tissue membrane
junctions [89, 109, 110]. It is expected that with these
developments, hand-held videomicroscopy will have
substantial benefits, including an early, sensitive diagnosis
of cardiovascular compromise and an optimization of
therapeutic interventions that restore the function of the
vulnerable MC in critically ill pediatric patients.
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